May 15, 2026 08:00AM
Apr 30, 2026 04:05PM
Apr 2, 2026 08:00AM
Apr 2, 2026 08:00AM
Mar 31, 2026 08:05AM
Mar 31, 2026 08:00AM
Mar 9, 2026 08:00AM Cocrystal Pharma begins dosing first subjects in norovirus drug trial
Mar 9, 2026 08:00AM
Dec 18, 2025 08:00AM
Dec 18, 2025 08:00AM
Nov 14, 2025 08:00AM
Sep 12, 2025 08:02AM
Sep 12, 2025 08:00AM
Sep 8, 2025 08:04AM Cocrystal Pharma gets FDA clearance for norovirus drug study
Sep 8, 2025 08:00AM
Aug 5, 2025 08:00AM
Aug 5, 2025 08:00AM
Jul 10, 2025 08:00AM
Jun 5, 2025 08:00AM
May 15, 2025 08:00AM
Apr 24, 2025 08:00AM Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
Mar 31, 2025 08:00AM
Nov 13, 2024 08:00AM
Aug 14, 2024 08:00AM
Jun 20, 2024 08:00AM
May 14, 2024 08:45AM
May 13, 2024 08:00AM
May 1, 2024 08:00AM Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
Mar 28, 2024 08:00AM
Mar 19, 2024 08:02AM
Mar 19, 2024 08:00AM
Nov 13, 2023 08:00AM
Aug 14, 2023 08:00AM
May 15, 2023 08:00AM
Mar 29, 2023 08:03AM Cocrystal Pharma (COCP) Reports FY22 Results, Provides Updates on its Antiviral Drug Development Programs
Mar 29, 2023 08:00AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Aug 15, 2022 08:00AM
Aug 15, 2022 08:00AM
May 11, 2022 08:06AM
May 11, 2022 08:00AM Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
May 11, 2022 08:00AM
Mar 23, 2022 04:05PM
Mar 23, 2022 04:05PM
Mar 3, 2022 08:00AM
Mar 3, 2022 08:00AM
Jan 27, 2022 08:02AM
Jan 27, 2022 08:00AM Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program
Jan 27, 2022 08:00AM

323,958 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All